<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink">
	
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">elife</journal-id>
			<journal-id journal-id-type="hwp">eLife</journal-id>
			<journal-id journal-id-type="publisher-id">eLife</journal-id>
			<journal-title-group>
				<journal-title>eLife</journal-title>
			</journal-title-group>
			<issn pub-type="epub">2050-084X</issn>
			<publisher>
				<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">01776</article-id>
			<article-id pub-id-type="doi">10.7554/eLife.01776</article-id>
			<article-categories>
				<subj-group subj-group-type="display-channel">
					<subject>Research Article</subject>
				</subj-group>
				<subj-group subj-group-type="heading">
					<subject>Genes and Chromosomes</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>p50-Associated COX2 Extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author" id="author-8985">
					<name>
						<surname>Krawczyk</surname>
						<given-names>Michal</given-names>
					</name>
					<aff>
						<addr-line>
							<named-content content-type="department">Regulatory Biology Laboratory</named-content>
						</addr-line>
						, 
						<institution>Salk Institute for Biological Studies</institution>
						, 
						<addr-line>
							<named-content content-type="city">La Jolla</named-content>
						</addr-line>
						, 
						<country>United States</country>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
				<contrib contrib-type="author" corresp="yes" id="author-1426">
					<name>
						<surname>Emerson</surname>
						<given-names>Beverly M</given-names>
					</name>
					<aff>
						<addr-line>
							<named-content content-type="department">Regulatory Biology Laboratory</named-content>
						</addr-line>
						, 
						<institution>Salk Institute for Biological Studies</institution>
						, 
						<addr-line>
							<named-content content-type="city">La Jolla</named-content>
						</addr-line>
						, 
						<country>United States</country>
						<email>emerson@salk.edu</email>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
			</contrib-group>
			<contrib-group content-type="section">
				<contrib contrib-type="editor" id="author-1082">
					<name>
						<surname>Espinosa</surname>
						<given-names>Joaquin M</given-names>
					</name>
					<role>Reviewing editor</role>
					<aff>
						<institution>HHMI / University of Colorado at Boulder</institution>
						, 
						<country>United States</country>
					</aff>
				</contrib>
			</contrib-group>
			<pub-date date-type="pub" publication-format="electronic"><day>29</day><month>04</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e01776</elocation-id>
			<supplementary-material><ext-link xlink:href="elife-01776-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history>
				<date date-type="received">
					<day>24</day>
					<month>10</month>
					<year>2013</year>
				</date>
				<date date-type="accepted">
					<day>11</day>
					<month>04</month>
					<year>2014</year>
				</date>
			</history>
			<permissions>
				<copyright-statement>Copyright © 2014, Krawczyk et al</copyright-statement>
				<copyright-year>2014</copyright-year>
				<copyright-holder>Krawczyk et al</copyright-holder>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
					<license-p>
						This article is distributed under the terms of the 
						<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link>
						, which permits unrestricted use and redistribution provided that the original author and source are credited.
					</license-p>
				</license>
			</permissions>
			<abstract>
				<p>Deregulated expression of COX-2 has been causally linked to development, progression and outcome of several types of human cancer. We describe a novel fundamental level of transcriptional control of COX-2 expression. Using primary human mammary epithelial cells and monocyte/macrophage cell lines we show that the chromatin boundary/insulator factor CTCF establishes an open chromatin domain and induces expression of a long non-coding RNA within the upstream promoter region of COX-2. Upon induction of COX-2 expression, the lncRNA associates with p50, a repressive subunit of NF-κB, and occludes it from the COX-2 promoter, potentially facilitating interaction with activation-competent NF-κB p65/p50 dimers. This enables recruitment of the p300 histone acetyltransferase, domain-wide increase in histone acetylation and assembly of RNA Polymerase II initiation complexes. Our findings reveal an unexpected mechanism of gene control by lncRNA-mediated repressor occlusion and identify the COX-2-lncRNA, PACER, as a new potential target for COX-2-modulation in inflammation and cancer.</p>
			</abstract>
			<kwd-group kwd-group-type="research-organism">
				<title>Research organism</title>
				<kwd>Human</kwd></kwd-group>
		</article-meta>
	</front>
	<back>
		<fn-group content-type="competing-interest">
			<title>Competing interest</title>
			<fn fn-type="conflict" id="conf1">
				<p>The authors declare that no competing interests exist.</p>
			</fn>
		</fn-group>
	</back>
</article>